VitaNova Life Sciences (VNOV) Notes Payables (2017)
VitaNova Life Sciences' (VNOV) quarterly Notes Payables came in at $6000.0 in Q2 2017.
VitaNova Life Sciences (VNOV) Notes Payables (2017) Analysis & Trends
VitaNova Life Sciences (VNOV) has 1 years of Notes Payables data on file, last reported at $6000.0 in Q2 2017.
- Quarterly Notes Payables changed N/A year-over-year to $6000.0 in Q2 2017, while the trailing twelve-month figure through Apr 2017 was $6000.0 (changed N/A YoY) and the FY2017 annual result came in at $6000.0, changed N/A from the prior year.
- Notes Payables was little changed at $6000.0 in Q2 2017.
- In the past five years, Notes Payables ranged from a high of $6000.0 in Q2 2017 to a low of $6000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 102.58 Bn | 97.42 Bn | 3.69 Bn |
| 2 | Cencora | 61.77 Bn | 58.96 Bn | 3.61 Bn |
| 3 | Cardinal Health | 54.17 Bn | 49.32 Bn | 2.56 Bn |
| 4 | Henry Schein | 10.06 Bn | 9.90 Bn | 1.10 Bn |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - |
| 6 | Edap Tms | 156.12 Mn | 134.57 Mn | 7.34 Mn |
| 7 | Accendra Health | 93.18 Mn | 85.53 Mn | 263.41 Mn |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn |
| 9 | Cosmos Health | 13.21 Mn | 10.76 Mn | 1.51 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2017 | 6,000.00 |